» Articles » PMID: 1383322

Interactions of Tumor Necrosis Factor with Granulocyte-macrophage Colony-stimulating Factor and Other Cytokines in the Regulation of Dendritic Cell Growth in Vitro from Early Bipotent CD34+ Progenitors in Human Bone Marrow

Overview
Journal J Immunol
Date 1992 Oct 15
PMID 1383322
Citations 62
Authors
Affiliations
Soon will be listed here.
Abstract

Colonies of CD1a+ HLA-DR+/DQ+ CD4+ cells with the functional and some of the structural attributes of Langerhans cells are observed in human bone marrow cultures in semi-solid media and are assumed to be the progeny of an early progenitor, the dendritic/Langerhans cell CFU (CFU-DL). The cytokine-regulated growth of these cells has been studied using a chemically defined serum-free system to culture both unfractionated and highly enriched bone marrow progenitor cell populations. Although unfractionated cell growth was optimal in serum replete cultures with PHA-stimulated leukocyte-conditioned medium (PHA-LCM) suboptimal proliferation of CFU-DL was observed in serum even in the absence of PHA-LCM. No colonies were observed under serum-free conditions when granulocyte-macrophage CSF (GM-CSF), IL-3, granulocyte CSF (G-CSF), and macrophage CSF (M-CSF) were present at levels optimal for granulocyte colony-forming unit (CFU-G) and macrophage colony-forming unit (CFU-M) growth. Addition of IL-1 alpha to these cytokines stimulated a small number of CFU-DL. However, in the presence of GM-CSF and IL-3, TNF-alpha or TNF-beta (5 U/ml) were both highly effective in promoting growth up to 82% of optimal and CFU-G growth was also enhanced at these concentrations. TNF was only active during the first 3 days of culture and higher concentrations of TNF-alpha but not TNF-beta were inhibitory for both CFU-DL and CFU-G. CD34+ cell-enriched populations were also enriched for both myeloid progenitors (CFU-G + CFU-M) and CFU-DL to 36- and 48-fold, respectively, and single cell cultures of CD34+ cells yielded single colonies containing both CD1a+ dendritic cells and CD1a- macrophages. Thus dendritic/Langerhans progenitors in the bone marrow expresses CD34, have a capacity for both macrophage and dendritic cell differentiation, and depend on hemopoietic growth factors and TNF for their further development in vitro.

Citing Articles

Prevalence of the fusion gene and T cell stimulation capacity of dendritic cells in chronic myelogenous leukemia.

Gaafar A, Al-Omar H, Manogaran P, Almohareb F, Alhussein K Am J Transl Res. 2023; 15(2):967-981.

PMID: 36915720 PMC: 10006767.


GM-CSF Monocyte-Derived Cells and Langerhans Cells As Part of the Dendritic Cell Family.

Lutz M, Strobl H, Schuler G, Romani N Front Immunol. 2017; 8:1388.

PMID: 29109731 PMC: 5660299. DOI: 10.3389/fimmu.2017.01388.


Replicate in Bone Marrow-Derived CD11c Cells but Not in Dendritic Cells Isolated from the Murine Gastrointestinal Tract.

Jones G, Smith V, DOrazio S J Immunol. 2017; 199(11):3789-3797.

PMID: 29055001 PMC: 5698106. DOI: 10.4049/jimmunol.1700970.


Sensitivity of Dendritic Cells to Microenvironment Signals.

Motta J, Rumjanek V J Immunol Res. 2016; 2016:4753607.

PMID: 27088097 PMC: 4819111. DOI: 10.1155/2016/4753607.


Generation of Tolerogenic Dendritic Cells and Their Therapeutic Applications.

Yoo S, Ha S Immune Netw. 2016; 16(1):52-60.

PMID: 26937232 PMC: 4770100. DOI: 10.4110/in.2016.16.1.52.